ASCO: Low-Fat Dietary Pattern Cuts Breast Cancer Deaths
THURSDAY, May 16, 2019 -- A low-fat dietary intervention is associated with reductions in deaths after breast cancer and deaths from breast cancer among postmenopausal women after long-term follow-up, according to a study scheduled to be presented at the annual meeting of the American Society for Clinical Oncology, held from May 31 to June 4 in Chicago.
Rowan T. Chlebowski, M.D., Ph.D., from the Los Angeles BioMedical Research Institute in Torrance, California, and colleagues conducted the randomized Women's Health Initiative Dietary Modification clinical trial, which involved 48,835 postmenopausal women aged 50 to 79 years with no previous breast cancer. Women were randomly assigned from 1993 to 1998 to either usual diet (60 percent) or a dietary intervention group with goals to reduce fat intake to 20 percent of energy and increase vegetables, fruit, and grain intake (40 percent).
The researchers observed a significant reduction in fat intake and increase in fruit, vegetable, and grain intake with the dietary intervention, with modest weight loss (3 percent). Deaths after breast cancer were significantly reduced in the intervention group during the intervention (hazard ratio, 0.65) and through 16.1 years of cumulative follow-up. After a cumulative follow-up of 19.6 years, with 3,374 incident breast cancers, the significant reduction in deaths after breast cancer persisted (hazard ratio, 0.85) and there was a significant reduction in deaths from breast cancer (hazard ratio, 0.79).
"These findings provide the first randomized clinical trial evidence that a dietary change can reduce a postmenopausal woman's risk of dying from breast cancer," the authors write.
© 2020 HealthDay. All rights reserved.
Posted: May 2019
More News Resources
- FDA Medwatch Drug Alerts
- Daily MedNews
- News for Health Professionals
- New Drug Approvals
- New Drug Applications
- Drug Shortages
- Clinical Trial Results
- Generic Drug Approvals
- Monthly Update Archive
Subscribe to our Newsletter
Whatever your topic of interest, subscribe to our newsletters to get the best of Drugs.com in your inbox.